Vol.
37
No.
6
February 11, 2011Feb 11, 2011

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

Sponsors Withdraw Indications for Iressa, Celebrex

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

White House Yet To Name NCAB, Cancer Panel Members

NCI Largely Unaffected By NIH Translational Research Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login